BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36402828)

  • 1. Influence of radiation treatment technique (IMRT vs. 3D-RT) on acute toxicity and prognostic factors for survival for anal cancer.
    Sauter C; Peeken JC; Borm K; Diehl CD; Münch S; Combs SE; Dapper H
    Sci Rep; 2022 Nov; 12(1):19914. PubMed ID: 36402828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved treatment outcome and lower skin toxicity with intensity-modulated radiotherapy vs. 3D conventional radiotherapy in anal cancer.
    Sauter M; Lombriser N; Bütikofer S; Keilholz G; Kranzbühler H; Heinrich H; Rogler G; Vavricka SR; Misselwitz B
    Strahlenther Onkol; 2020 Apr; 196(4):356-367. PubMed ID: 31980834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.
    Koerber SA; Slynko A; Haefner MF; Krug D; Schoneweg C; Kessel K; Kopp-Schneider A; Herfarth K; Debus J; Sterzing F
    Radiat Oncol; 2014 May; 9():113. PubMed ID: 24886574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.
    Elson JK; Kachnic LA; Kharofa JR
    Cancer; 2018 Nov; 124(22):4383-4392. PubMed ID: 30329160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
    Chen NB; Qiu B; Zhang J; Qiang MY; Zhu YJ; Wang B; Guo JY; Cai LZ; Huang SM; Liu MZ; Li Q; Hu YH; Li QW; Liu H
    Cancer Res Treat; 2020 Jan; 52(1):31-40. PubMed ID: 31048664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
    Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
    Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
    Dewas CV; Maingon P; Dalban C; Petitfils A; Peignaux K; Truc G; Martin E; Khoury C; Dewas S; Créhange G
    Radiat Oncol; 2012 Nov; 7():201. PubMed ID: 23190693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analysis of conformal and intensity-modulated radiotherapy in patients with recurrent ovarian cancer.
    Yang H; Zhang K; Liu Z; Wang T; Shi F; Su J; Zhang J; Liu J; Dai L
    Sci Rep; 2020 Oct; 10(1):17172. PubMed ID: 33057094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
    Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
    Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Kuang WL; Zhou Q; Shen LF
    Clin Transl Oncol; 2012 Oct; 14(10):783-90. PubMed ID: 22855156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
    Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
    Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy.
    Ito M; Kodaira T; Tachibana H; Tomita N; Makita C; Koide Y; Kato D; Abe T; Muro K; Tajika M; Niwa Y; Hasegawa Y
    Head Neck; 2017 Dec; 39(12):2406-2415. PubMed ID: 28960561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal.
    Chuong MD; Freilich JM; Hoffe SE; Fulp W; Weber JM; Almhanna K; Dinwoodie W; Rao N; Meredith KL; Shridhar R
    Gastrointest Cancer Res; 2013 Mar; 6(2):39-45. PubMed ID: 23745158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience.
    Jethwa KR; Day CN; Sandhyavenu H; Gonuguntla K; Harmsen WS; Breen WG; Routman DM; Garda AE; Hubbard JM; Halfdanarson TR; Neben-Wittich MA; Merrell KW; Hallemeier CL; Haddock MG
    Clin Transl Radiat Oncol; 2021 May; 28():17-23. PubMed ID: 33732911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 3D conformal radiation therapy and intensity-modulated radiation therapy in patients with endometrial cancer: efficacy, safety and prognostic analysis.
    Ta MH; Schernberg A; Giraud P; Monnier L; Darai É; Bendifallah S; Schlienger M; Touboul E; Orthuon A; Challand T; Huguet F; Rivin Del Campo E
    Acta Oncol; 2019 Aug; 58(8):1127-1134. PubMed ID: 31017032
    [No Abstract]   [Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
    Dell'Acqua V; Surgo A; Arculeo S; Zerella MA; Bagnardi V; Frassoni S; Zampino MG; Ravenda PS; Rotundo MS; Kraja F; Kobiela J; Spychalski P; Fodor C; Gerardi MA; Cattani F; Bazani A; Petz W; Glynne-Jones R; Orecchia R; Leonardi MC; Jereczek-Fossa BA
    Int J Colorectal Dis; 2020 Apr; 35(4):685-694. PubMed ID: 32036405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.